Get Up To Date Event Information

Join our priority contact list and receive the latest event news.

Special Discounted Hotel Rate

Special Discounted Hotel Rate Available Until May 11, 2012.
To book your room, call 888-627-8561 and mention that you are an IBC attendee at this event.

New to the Field?

Attend the Two-Day Short Course:
Introduction to Vaccine Development & Manufacturing
Tuesday-Wednesday, June 5-6, 2012
(Separate Registration Required - Add Monday for a 3-Day Package)

Attend Co-Located Conference at No Extra Charge

IBC's 9th International
Single-Use Applications for Biopharmaceutical Manufacturing
Fostering Industry Collaboration Toward Standards Harmonization and Technology Innovation in Single-Use Systems
June 4-6, 2012

Call for Posters

Submit your Abstract Today
Deadline to Submit is May 4, 2012

See the slides from this presentation at last year's conference:

A Hybrid Single‐Use Bioreactor for Scale‐up of Virus Vaccine Production Using Continuous Cell Lines
Cynthia Elias, Sanofi Pasteur

As your company advances its vaccine development efforts to serve new indications and the surging global vaccines markets, it is important for you to optimize your production steps from development through commercial production.

IBC's Vaccine Production Summit, combined with the co-located Single-Use Applications for Biopharmaceutical Manufacturing conference, is the perfect opportunity for you to hear how other companies (large and small) have solved common process development and manufacturing problems. And by having two audiences in attendance, you'll double your opportunities for networking, scientific collaboration and business development.

Keynote Presentations

The Regulatory Pathway for Next Generation Adjuvanted Vaccines
Norman W. Baylor, Ph.D., President & Chief Executive Officer, Biologics Consulting Group, Inc.; former Director, Office of Vaccines Research and Review (OVRR), US Food and Drug Administration (FDA)

Single Use Process Components: Challenges and Opportunities for Manufacturing at Industrial Scale
Peter Kraemer, Ph.D., Head Engineering Process Development and Large Scale Fermentation, Sanofi SA, Germany

Attendees Will Learn:

• How to navigate the regulatory pathways for evaluating and licensing next generation adjuvanted vaccines
• Perspectives on the aspects of process development that impact long term manufacturing success across the supply chain
• Strategies for the scale up and transfer of lyophilization processes in moving to commercial scale production
• How disposable components facilitate reducing the COGS for animal health vaccines
• Best practices for managing the impacts of excipient changes during formulation development for live virus vaccines
• Strategies for developing, validating and maintaining potency assays for vaccines

All-New Sessions for 2012:

• Improving the Quality and Throughput of Vaccine Production
• Vaccine Production in International Markets
• Process Development for Vaccines
• Using Single Use Components in Vaccine Production
• Formulation Issues in Vaccine Development
• The Application of Quality by Design Concepts in Vaccine Development
• Characterization Studies in Support of Vaccine Production
• Course: Introduction to Vaccine Development & Manufacturing